|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Boyages J, Chua B, Taylor R, Bilous M,
Salisbury E, Wilcken N and Ung O: Use of the St Gallen
classification for patients with node-negative breast cancer may
lead to overuse of adjuvant chemotherapy. Br J Surg. 89:789–796.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colomer R, Viñas G, Beltran M, et al:
Validation of the 2001 St Gallen risk categories for node-negative
breast cancer using a database from the Spanish Breast Cancer
Research Group (GEICAM). J Clin Oncol. 22:961–962. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lundin J, Lehtimäki T, Lundin M, et al:
Generalisability of survival estimates for patients with breast
cancer--a comparison across two population-based series. Eur J
Cancer. 42:3228–3235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olivotto IA, Bajdik CD, Ravdin PM, et al:
Population-based validation of the prognostic model ADJUVANT! for
early breast cancer. J Clin Oncol. 23:2716–2725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cronin M, Pho M, Dutta D, et al:
Measurement of gene expression in archival paraffin-embedded
tissues: development and performance of a 92-gene reverse
transcriptase-polymerase chain reaction assay. Am J Pathol.
164:35–42. 2004. View Article : Google Scholar
|
|
7
|
Sørlie T, Perou CM, Tibshirani R, et al:
Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications. Proc Natl Acad Sci USA.
98:10869–10874. 2001.PubMed/NCBI
|
|
8
|
Perou CM, Sørlie T, Eisen MB, et al:
Molecular portraits of human breast tumours. Nature. 406:747–752.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Klijn JGM, Zhang Y, et al:
Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
West M, Blanchette C, Dressman H, et al:
Predicting the clinical status of human breast cancer by using gene
expression profiles. Proc Natl Acad Sci USA. 98:11462–11467. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van ‘t Veer LJ, Dai H, van de Vijver MJ,
et al: Gene expression profiling predicts clinical outcome of
breast cancer. Nature. 415:530–536. 2002.PubMed/NCBI
|
|
12
|
Meng S, Tripathy D, Frenkel EP, et al:
Circulating tumor cells in patients with breast cancer dormancy.
Clin Cancer Res. 10:8152–8162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vessella RL, Pantel K and Mohla S: Tumor
cell dormancy: an NCI workshop report. Cancer Biol Ther.
6:1496–1504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fehm T, Braun S, Muller V, et al: A
concept for the standardized detection of disseminated tumor cells
in bone marrow from patients with primary breast cancer and its
clinical implementation. Cancer. 107:885–892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Braun S and Marth C: Circulating tumor
cells in metastatic breast cancer - toward individualized
treatment? N Engl J Med. 351:824–826. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braun S, Vogl F and Naume B: A pooled
analysis of bone marrow micrometastasis in breast cancer. N Engl J
Med. 353:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allard WJ, Matera J, Miller MC, et al:
Tumor cells circulate in the peripheral blood of all major
carcinomas but not in healthy subjects or patients with
nonmalignant diseases. Clin Cancer Res. 10:6897–6904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cristofanilli M and Budd G: Circulating
tumor cells, disease progression, and survival in metastatic breast
cancer. Engl J Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu MC, Shields PG, Warren RD, et al:
Circulating tumor cells: a useful predictor of treatment efficacy
in metastatic breast cancer. J Clin Oncol. 27:5153–5159. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pierga JY, Hajage D, Bachelot T, et al:
High independent prognostic and predictive value of circulating
tumor cells compared with serum tumor markers in a large
prospective trial in first-line chemotherapy for metastatic breast
cancer patients. Ann Oncol. 23:618–624. 2012. View Article : Google Scholar
|
|
21
|
Bidard F, Peeters D and Fehm T: Clinical
validity of circulating tumour cells in patients with metastatic
breast cancer: a pooled analysis of individual patient data. Lancet
Oncol. 15:406–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Franken B, de Groot MR, Mastboom WJB,
Vermes I, van der Palen J, Tibbe AGJ and Terstappen LWMM:
Circulating tumor cells, disease recurrence and survival in newly
diagnosed breast cancer. Breast Cancer Res. 14:R1332012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mathiot C, Brain E, Delaloge S, Pierga J,
Marty M, Giachetti S and de Cremoux P: Circulating tumor cell
detection predicts early metastatic relapse after neoadjuvant
chemotherapy in large operable and locally advanced breast cancer
in a phase II randomized trial. Clin Cancer Res. 14:7004–7010.
2008. View Article : Google Scholar
|
|
24
|
Jueckstock JK, Rack BK, Zwingers T, Hepp
PGM, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer HL, Pantel
K, Tesch H, Forstbauer H, Lorenz R, Rezai M, Neugebauer JK,
Andergassen U, Friese K, et al: Prognostic relevance of circulating
tumor cells (CTC) before adjuvant chemotherapy in patients with
breast cancer: results of the German SUCCESS trial. J Clin Oncol.
29(Suppl): 10332011.
|
|
25
|
Lucci A, Hall CS, Lodhi AK, et al:
Circulating tumour cells in non-metastatic breast cancer: a
prospective study. Lancet Oncol. 13:688–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Janni WJ, Rack BK, Terstappen LWMM, et al:
A pooled analysis of the prognostic relevance of circulating tumor
cells in early breast cancer. Cancer Res. 73(Suppl 24): PD6–6.
2013. View Article : Google Scholar
|
|
27
|
Bidard FC, Mathiot C, Delaloge S, et al:
Single circulating tumor cell detection and overall survival in
nonmetastatic breast cancer. Ann Oncol. 21:729–733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
National guidelines breast cancer
(richlijn mamacarcinoom 2008). http://www.cbo.nl.
|
|
29
|
R Core Team. R: A Language and Environment
for Statistical Computing. Version 3.0.1 (2013-05-16).
|
|
30
|
Coumans FAW, Ligthart ST, Uhr JW and
Terstappen LWMM: Challenges in the enumeration and phenotyping of
CTC. Clin Cancer Res. 18:5711–5718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Coumans FAW, Ligthart ST and Terstappen
LWMM: Interpretation of changes in circulating tumor cell counts.
Transl Oncol. 5:486–491. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barradas AM and Terstappen LWMM: Towards
the biological understanding of CTC: capture technologies,
definitions and potential to create metastasis. Cancers (Basel).
5:1619–1642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fischer JC, Niederacher D, Topp SA, et al:
Diagnostic leuka-pheresis enables reliable detection of circulating
tumor cells of nonmetastatic cancer patients. Proc Natl Acad Sci
USA. 110:16580–16585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coumans FAW, Siesling S and Terstappen
LWMM: Detection of cancer before distant metastasis. BMC Cancer.
13:2832013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pierga JY, Bidard FC, Mathiot C, et al:
Circulating tumor cell detection predicts early metastatic relapse
after neoadjuvant chemotherapy in large operable and locally
advanced breast cancer in a phase II randomized trial. Clin Cancer
Res. 14:70042008. View Article : Google Scholar
|
|
36
|
Van Dalum G, de Groot M, Stam GJ, et al:
Importance of circulating tumor cells in newly diagnosed colorectal
cancer. In: Proc 105th Annual Meeting Amer Assoc for Cancer Res;
San Diego, CA. abst 3064. 2014, PubMed/NCBI
|
|
37
|
Ligthart ST, Coumans FAW, Attard G,
Cassidy AM, de Bono JS and Terstappen LWMM: Unbiased and automated
identification of a circulating tumour cell definition that
associates with overall survival. PLoS One. 6:e274192011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Swennenhuis JF, Tibbe AGJ, Levink R,
Sipkema RCJ and Terstappen LWMM: Characterization of circulating
tumor cells by fluorescence in situ hybridization. Cytometry A.
75:520–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Swennenhuis JF, Reumers J, Thys K,
Aerssens J and Terstappen LWMM: Efficiency of whole genome
amplification of single circulating tumor cells enriched by
CellSearch and sorted by FACS. Genome Med. 5:1062013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Klein CA, Blankenstein TJF,
Schmidt-Kittler O, Petronio M, Polzer B and Stoecklein NH:
Mechanisms of disease Genetic heterogeneity of single disseminated
tumour cells in minimal residual cancer. Lancet. 360:683–689. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meng S, Tripathy D, Shete S, et al: uPAR
and HER-2 gene status in individual breast cancer cells from blood
and tissues. Proc Natl Acad Sci USA. 103:17361–17365. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fehm T, Sagalowsky A, Clifford E, et al:
Cytogenetic evidence that circulating epithelial cells in patients
with carcinoma are malignant. Clin Cancer Res. 8:2073–2084.
2002.
|
|
43
|
Meng S, Tripathy D, Shete S, et al: HER-2
gene amplification can be acquired as breast cancer progresses.
Proc Natl Acad Sci USA. 101:9393–9398. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Uhr JW and Pantel K: Controversies in
clinical cancer dormancy. Proc Natl Acad Sci USA. 108:12396–12400.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sieuwerts AM, Kraan J, Bolt J, et al:
Anti-epithelial cell adhesion molecule antibodies and the detection
of circulating normal-like breast tumor cells. J Natl Cancer Inst.
101:61–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mostert B, Kraan J, Sieuwerts AM, et al:
CD49f-based selection of circulating tumor cells (CTCs) improves
detection across breast cancer subtypes. Cancer Lett. 319:49–55.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Coumans FAW, van Dalum G, Beck M and
Terstappen LWMM: Filter characteristics influencing circulating
tumor cell enrichment from whole blood. PLoS One. 8:e617702013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hou HW, Warkiani ME, Khoo BL, et al:
Isolation and retrieval of circulating tumor cells using
centrifugal forces. Sci Rep. 3:12592013.PubMed/NCBI
|
|
49
|
Vona G, Sabile A, Louha M, et al:
Isolation by size of epithelial tumor cells: a new method for the
immunomorphological and molecular characterization of
circulatingtumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
